ILIAD BIOTECHNOLOGIES, LLC
ID: 6045547ILIAD BIOTECHNOLOGIES, LLC is a pertussis Vaccine founded in 2012 by Keith Rubin, M.D..
9
Funding Rounds
$102.9m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ke*** Ru**** M.** |
|
- | - |
Funding series
Funding Series Analysis
The company ILIAD BIOTECHNOLOGIES, LLC has raised a total of $42.84m in funding over 9 rounds.
Key Insights:
- ILIAD BIOTECHNOLOGIES, LLC Funding Round, September 2022: $42.84m
- ILIAD BIOTECHNOLOGIES, LLC funding round, November 2019: $3.4m
- ILIAD BIOTECHNOLOGIES, LLC funding round, December 2018: $20m
- ILIAD BIOTECHNOLOGIES, LLC funding round, August 2018: $5m
- ILIAD BIOTECHNOLOGIES, LLC funding round, February 2018: $5m
- ILIAD BIOTECHNOLOGIES, LLC funding round, April 2017: $1.25m
- ILIAD BIOTECHNOLOGIES, LLC funding round, August 2016: $955k
- ILIAD BIOTECHNOLOGIES, LLC funding round, November 2015: $1m
- ILIAD BIOTECHNOLOGIES, LLC funding round, March 2021: $23.5m
Industries
ILIAD BIOTECHNOLOGIES, LLC is active in the following industries: